<p>The invention is directed to the field of cancer therapy, specifically to the use of anti-CCL20 antibodies for the treatment of neoplastic disorders. The invention provides compositions and methods useful for the treatment of CCR6 and CXCR4 expressing tumors.</p>
申请公布号
WO2009156994(A1)
申请公布日期
2009.12.30
申请号
WO2009IL00631
申请日期
2009.06.24
申请人
HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENTLTD.;PELED, AMNON;BEIDER, KATIA
